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doi:10.1016/j.jfma.2012.03.003Background/Purpose: Though intraoperative nerve monitoring (IONM) during thyroid surgery has
gained universal acceptance for localizing and identifying the recurrent laryngeal nerve (RLN), its
role in reducing the rate of RLN injury remains controversial. In order to assess the effect of IONM
during thyroid surgery, its value in reducing the incidenceofRLNpalsywas systematically evaluated.
Methods: Studies were evaluated for inclusion in this analysis by researching PubMed, Embase, the
Cochrane Central Register of Controlled Trials, and the references of included studies. The initial
screening of article titles and abstracts was independently performed by five reviewers based on
the research protocol criteria. Each article was then read in detail and discussed before inclusion
in the meta-analysis. Data were independently extracted, including the level of evidence, number
of at-risk nerves, allocationmethod, baseline equivalence between groups, definitions of transient
and permanent vocal fold palsy, systematic application of electrodes, etc. The meta-analysis was
then performed. Odds ratios were pooled using a random effects model.
Results: Five randomized clinical trials and 12 comparative trials evaluating 36,487 at-risk nerves
were included. Statistically significant differences in terms of total recurrent laryngeal nerve palsy
(3.37% with intraoperative nerve monitoring [IONM] vs. 3.76% without IONM [OR: 0.74; 95% confi-
dence interval [CI]: 0.59e0.92]) and transient recurrent laryngeal nerve palsy (2.56% with IONM
vs. 2.71% without IONM [OR: 0.80; 95% CI: 0.65e0.99]) were identified. The persistent incidence
of recurrent laryngeal nerve palsy was 0.78% for IONM versus 0.96% for nerve identification alone
(OR: 0.80; 95% CI: 0.62e1.03).
Conclusion: Based on this meta-analysis, statistically significant differences were determined in
termsof the incidencesof total and transient recurrent laryngeal nervepalsy afterusing IONMversusof Otolaryngology Head and Neck Surgery, First Affiliated Hospital of Guangxi Medical University,
Guangxi 530021, China.
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464 S. Zheng et al.recurrent laryngeal nerve identification alone during thyroidectomy. However, no statistically
significant differences were identified regarding the incidence of persistent recurrent laryngeal
nerve palsy between groups.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Recurrent laryngeal nerve (RLN) injury has been a frequent
source of malpractice litigation following thyroid surgery
over the last 20 years.1 The average incidences of perma-
nent and temporary RLN palsy after thyroid operations
are high (2.3% and 9.8%, respectively), as verified by
systematic and rigorous postoperative laryngoscopy.2 Most
surgeons apply their best efforts to prevent this consider-
able postoperative complication, which involves hoarse-
ness, impaired vocal register, dysphonia, dysphagia, and
aspiration dyspnea.3 The rate of RLN palsy depends on the
type of disease (benign or malignant), the extent of thyroid
resection (subtotal or total thyroidectomy), the type of
resection (first time or reoperation), the surgical device
used (with or without routine RLN identification), and the
training and/or experience of the surgeon.4e6 Surgical
exposure and anatomic identification of the RLN during
thyroid operations has been shown to provide the best way
of keeping the incidence of nerve injury to a minimum.7
However, even experienced surgeons can inadvertently
injure the nerve due to variability in RLN anatomy and
difficulties in nerve identification that can occur under
challenging conditions.8
Intraoperative nerve monitoring (IONM) during thyroid
surgery has gained universal acceptance as an adjunct,
not only for localizing and identifying the RLN but also
as a way to predict vocal cord function and clarify the
mechanisms of RLN injury. The rates of the use of moni-
toring have recently become almost equivalent between
general surgery- and otolaryngology-trained surgeons, with
approximately 40e45% of surgeons in both groups using
IONM in some cases.9,10 However, its role in reducing the
rate of RLN injury remains controversial.11e23 Meta-analysis
may help to resolve such discrepancies.24 When individual
studies fulfill the criteria of combinability, meta-analysis
can increase the statistical power by providing combined
estimates of effect; however, if studies cannot be
combined, meta-analysis may be used to identify program
characteristics that might explain discrepancies.24,25 The
objective of this study was to systematically review the
evidence supporting the use of IONM to reduce the inci-
dence of RLN paralysis by IONM and to perform a meta-
analysis to compare the effects of IONM versus RLN
identification alone on the rate of RLN palsy in
thyroidectomy.Materials and methods
Article-selection process
The web-based PubMed database (1950 through April
2011), Embase (1974 through April 2011), and the CochraneCentral Register of Controlled Trials (CENTRAL, The Cochrane
Library, Issue 2 of 4, April 2011) were searched using the
terms “thyroid surgery,” “recurrent laryngeal nerve,” and
“nerve monitoring” along with their synonyms in order to
identify all articles relevant to the use of IONM of the RLN in
thyroid surgery (see Appendix 1). Excluded from this review
were review articles, original articles that were pure
descriptions of the methodology of IONM, animal studies,
uncontrolled studies, case series, case reports, expert
opinions, and studies that were published in languages
other than English. Articles regarding the influence of
muscle relaxation on neuromonitoring of the RLN during
thyroid surgery were also excluded from this review. In
addition, a reference- and related-article search was per-
formed. The articles that were generated in each step of
the search were then aggregated to produce an article list
for consideration.
Five investigators independently screened the article
titles and abstracts in order to evaluate relevant articles,
which included all randomized controlled trials (RCTs) and
cohort studies related to RLN monitoring during thyroid
surgery. The investigators then obtained the full texts that
were deemed relevant to the targeted research purposes
for further analysis (Fig. 1). Additional studies were iden-
tified by scanning the references of the initial studies.
Articles were then excluded from the final selected cohort
if they did not meet the original parameters of the search
criteria.
Data extraction and quality assessment
All articles that met the eligibility criteria were indepen-
dently reviewed by the three investigators for data
extraction and quality assessment. Data extracted from
each trial included the level of evidence (LOE),26 number of
nerves at risk (NAR), allocation method, baseline equiva-
lence between groups, the definitions of transient and
permanent vocal fold palsy, systematic application of
electrodes, country, and dates of during which the studies
were conducted. Primary outcome variables included total,
transient, and persistent RLN palsy. Total RLN palsy was
defined as transient RLN palsy in combination with perma-
nent RLN palsy.
Statistical analysis
In order to decrease heterogeneity across study inter-
ventions, statistical analyses were performed after all of
the authors had critically evaluated the articles and
decided on the final list of included articles. An odds ratio
(OR) of 0.5 was chosen to represent an estimate that could
be considered clinically significant and might change the
clinical decision. The results were pooled using RevMan
5.0.2327 meta-analysis software using the random effects
Figure 1 Flow diagram of article selection for inclusion in
this study.
Table 1 Grades of recommendation and levels of
evidence (adapted from the Oxford Centre for Evidence-
Based Medicin26).
GOR LOE Therapy/prevention/etiology/harm
A 1a SR (with homogeneity)of RCTs
1b Individual RCT (with narrow confidence
interval)
1c All or none
B 2a SR (with homogeneity) of cohort studies
2b Individual cohort study (including low quality
RCT; e.g., < 80% follow-up)
2c “Outcomes” research; ecological studies
3a SR (with homogeneity) of case-control studies
3b Individual case-control study
C 4 Case series (and poor quality cohort and case-
control studies)
D 5 Expert opinion without explicit critical
appraisal, based on physiology, bench research
or “first principles”
GOR Z grades of recommendation; LOE Z level of evidence;
RCT Z randomized controlled trial; SR Z systematic review.
Effect of intraoperative neuromonitoring 465Mantel-Haenszel model. The OR was used to reflect the
association across studies. Statistical heterogeneity was
calculated using Cochrane Q and the Tau2 statistics. The
potential sources of heterogeneity considered in the study
protocol included trial quality, the definitions of transient
and permanent vocal fold palsy, and the risk level of RLN.
Sensitivity analyses were also performed to assess whether
the principal conclusions were affected by basic assump-
tions. A funnel plot was constructed to evaluate data
symmetry and publication bias. Forest plots were gener-
ated to represent the OR with the corresponding 95%
confidence intervals (CI) across the included studies.
Results
Study selection and study characteristics
The electronic searches and review of the references yiel-
ded a total of 206 potentially relevant articles. Fig. 1 shows
the flowchart of the inclusion and exclusion of the potential
studies. During the review of the title, abstract, and full
text, an additional 192 articles were excluded, resulting in
14 articles that were finally included in this meta-analysis.
Two studies were multi-institutional. These studies collec-
tively enrolled a total of 36,487 NARs that had undergone
IONM. According to the Oxford Centre for Evidence-Based
Medicine (OCEBM),26 two and 12 articles were graded as
1b and 2b, respectively (Table 1).26 Additional details are
summarized in Table 2. Five studies were conducted in the
United States, four in Germany, and five in other countries
(China, Italy, Poland, Brazil, and Turkey). These studies
were published between 1992 and 2009.
The patient-allocation method for comparative studies
included random, consecutive allocation, surgeon prefer-
ence, and equipment availability. The timing of the initialpostoperative laryngoscopy varied from immediately post-
operative to within 2 weeks of surgery. Additionally,
persistent vocal fold palsy was variously defined as 3
months, 6 months, or even 12 months. Most studies did not
specify the primary surgeon but mentioned the exact ratios
of low- and high-volume surgeons.Risk of bias in the included studies
The risk of bias in the included studies is summarized in the
risk-of-bias graph (Fig. 2) and risk-of-bias summary (Fig. 3).
Only two of the 14 trials demonstrated adequate sequence
generation.5,11 None of the other 10 trials reported the
method used to generate the allocation sequence. Only one
trial performed allocation concealment.5 Only one trials
reported patient blinding.5 None of the other trials re-
ported patient or assessor blinding, which are theoretically
feasible in this comparison. Four trials reported post-
randomization drop-outs. However, one trial excluded
some patients from the analysis without interpretation.15
Therefore, this trial was considered to be at high risk of
bias from incomplete outcome data. The other studies did
not report the participant flow and we were incapable of
assessing bias from incomplete outcome data. Four of the
trials did not report all of the important outcomes (e.g.,
primary outcomes), and we were unable to acquire the
protocols of these trials. Therefore, we consider these four
trials to be at high risk of bias from selective outcome
reporting. Two trials did not report the participant char-
acteristics.21,22 Nine trials had adequately matched
participants to two groups and were free from baseline
imbalance bias. However, three trials did not adequately
match participants and were at risk of baseline imbalance
bias.12,13,16 The source of funding was described in seven
trials. Terris DJ served as a consultant for thyroid
Table 2 Characteristics of the included studies.
Author (y) LOE Allocation method Electrodes of
LEMG
Postoperative
laryngoscopy
timing (h)
Persistent
TVFP (mo)
Country, dates
Barczynski (2009)5 1b Random Needle electrodes <24 12 Poland, 2006e2007
Sarı (2010)11 1b Random Endotracheal tube
surface electrodes
>24 12 Turkey, 2007e2009
Dralle (2004)12 2b Equipment/surgeon Needle electrodes NS 6 Germany, 1998e2001
Robertson (2004)13 2b Consecutive Endotracheal tube
surface electrodes
NS NS USA, 1999e2002
Thomusch (2002)14 2b Equipment/surgeon Needle electrodes <24 6 Germany, 1998e1999
Shindo (2007)15 2b Consecutive Endotracheal tube
surface electrodes
<24 NS USA, 1998e2005
Terris (2007)16 2b NS Endotracheal tube
surface electrodes
<24 6 USA, 2004e2006
Netto (2007)17 2b Consecutive Endotracheal tube
surface electrodes
>24 3 Brazil, 2003e2006
Brauckhoff(2002)18 2b Consecutive Needle electrodes NS NS Germany, 1995e2001
Chan (2006)19 2b Equipment/surgeon Endotracheal tube
surface electrodes
>24 12 China, 2002e2005
Frattini (2010)20 2b Consecutive Needle electrodes >24 12 Italy, NS
Witt (2005)21 2b Consecutive Endotracheal tube
surface electrodes
NS 12 USA, 1998e2003
Agha (2008)22 2b NS NS NS 6 Germany, 1992e2005
Yarbrough (2004)23 2b Consecutive Hook-wise
electrodes
NS NS USA, 1998e2003
TVFP Z true vocal fold palsy; NS Z not stated; Equipment Z equipment availability; Surgeon Z surgeon preference; LOE Z level of
evidence.
466 S. Zheng et al.instrument development for Medtronic Xomed and directed
thyroid courses sponsored by Ethicon Endosurgery.16
Therefore, this trial was at risk of source-of-funding bias.
The sources of funding of the other six trials were medical
foundations, and we consider these trials to be free from
risk of source-of-funding bias. The source-of-funding bias
was unclear in the remaining seven trials, which did not
declare the sources of funding.Internal analyses and pooled analyses
The Cochrane Q and the Tau2 statistics (using a significance
threshold of p< 0.05) did not reveal significant statistical
heterogeneity among studies. The funnel plots indicated
a relatively perfect symmetrical distribution regarding the
rates of transient and persistent RLN palsy. However, mild
asymmetry was observed in the funnel plot of the total RLN
palsy rate (Fig. 4).
Fig. 5 shows the forest plots of all of the included
surgeries. The rate of total RLN palsy of the IONM group
and the without IONM group are 3.37% and 3.76%, respec-
tively. The rate of transient RLN nerve palsy (2.56% with
IONM vs. 2.71% without IONM) was identified. Additionally,
the persistent incidence of recurrent laryngeal nerve palsy
was 0.78% for IONM versus 0.96% for nerve identification
alone. The pooled adjusted ORs for the rates of total,
transient, and persistent RLN palsy, respectively, were 0.74
(0.59e0.92), 0.80 (0.65e0.99), and 0.80 (0.62e1.03). Whenthe total and transient RLN palsy rates were compared,
there was a significant difference between the two groups
(pZ 0.007 and 0.04, respectively). However, comparison of
the persistent RLN palsy rates between groups revealed no
statistically significant differences (pZ 0.08).
Sensitivity analyses
It is acknowledged that nerve damage is much higher in
reoperative cases of thyroid and parathyroid surgery. A
study conducted by Yarbrough et al predominantly focused
on reoperative thyroid and parathyroid surgery. It is
interesting to speculate whether the results would be the
same if this study was excluded. To test the sensitivity
of this meta-analysis, all analyses were repeated. The
combined ORs did not change substantially; ORs of 0.72
(0.57e0.91) for the total RLN palsy rate, 0.78 (0.62e0.97)
for the transient RLN palsy rate, and 0.80 (0.62e1.03)
for the permanent RLN palsy rate were returned upon
reanalysis.
Discussion
Although different types of IONM have been adopted,
many potential benefits and pitfalls have also been re-
ported. Nerve identification, which helps to differentiate
RLN from nonneural tissue, is a primary benefit of RLN
monitoring.11e23 Another benefit of IONM is dynamic and
Figure 2 Methodological quality summary: review authors’
judgments regarding each methodological quality item of each
included study.
Figure 3 Methodological quality graph: review authors’
judgments about each methodological quality item presented
as percentages for all included studies.
Effect of intraoperative neuromonitoring 467continuous audible and visual feedback of mechanically
evoked potentials so that the surgical methods can be
modified when something potentially harmful is being
done to the RLN, especially during a planned exploration
procedure in a patient at increased risk of bilateral nerve
injury.5,28e30 Moreover, by printing the electromyographic
signal of the evoked potentials, RLN monitoring allows
nerve function documentation both before and after
thyroid resection, which is of great importance in a society
with an increasing number of litigations.31,32 However,
there are several criticisms of the routine use of IONM,which are focused mainly on the increased cost of the
equipment (i.e., the cost of the special endotracheal tube
and the additional technical staff who intraoperatively
monitor the RLN).11,15,21 Another criticism is that it is time
consuming.23,33 The disadvantages associated with IONM
include false-negative and false-positive signals,28,29,34e38
which should not be neglected, as false-negative signals
can actually increase the risk of RLN injury if surgeons
exclusively rely on the monitoring system. Despite the
increasing popularity of the adoption of IONM, its role in
reducing the incidence of postoperative RLN palsy remains
doubtful. Additional evidence-based reviews of the clin-
ical utility of IONM are needed.
In this meta-analysis, when comparing the “with
IONM” and “without IONM” groups, a significant differ-
ence was observed in the reduction of the rates of total
and transient RLN palsies. But the reduction of the rates
of persistent RLN palsies was not observed in adequately
powered sample sizes. However, the sensitivity analysis
revealed that the pooled analysis of the rate of transient
RLN palsy was hypersensitive and unstable. Thus, we
may draw conclusions that IONM plays an important role
in reducing the rate of total RLN palsy but not the rate
of persistent RLN palsy. It is prudent to conclude that
IONM effectively decreases the rate of transient RLN
palsy.
Barczynski et al5 performed a medium-sized, single-
center, randomized, prospective study that compared the
frequency of transient RLN paresis after surgery between
RLN visualization alone and with IONM. This study
demonstrated that nerve monitoring decreases the inci-
dence of transient RLN paresis but not permanent RLN
paresis in comparison with visualization alone, particularly
in high-risk patients. To date, although this is the highest
level study performed, the results and conclusions are still
controversial. Nonrandomized comparative trials have
returned fairly accurate results, and their utilization has
been advocated for special conditions in which random-
ized trials are difficult to perform.13 Until further large-
scale randomized controlled trials (RCTs) can be per-
formed, data from published nonrandomized studies can
be used for such comparisons, as shown above.25,39 Due to
insufficient numbers, most of the included studies failed
to demonstrate that a statistically significant difference
Figure 4 Funnel plots depicting the odds ratios (ORs) with 95% confidence intervals (CI) and standard errors (SE) for total (A),
transient (B), and persistent (C) recurrent laryngeal nerve palsies in the included studies. Total recurrent laryngeal nerve palsy is
defined as transient recurrent laryngeal nerve palsy in combination with permanent recurrent laryngeal nerve palsy.
Figure 5 Forest plots showing the distributions of (A) total recurrent laryngeal nerve palsy, (B) transient recurrent laryngeal
nerve palsy, and (C) persistent recurrent laryngeal nerve palsy. Total recurrent laryngeal nerve palsy is defined as transient
recurrent laryngeal nerve palsy in combination with permanent recurrent laryngeal nerve palsy. CI Z confidence interval.
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Effect of intraoperative neuromonitoring 469between the two groups of unintentional RLN injury
actually existed.14 Large prospective randomized trials
that address these issues are rare because of the large
numbers of patients required (> 7000 per arm) to indicate
a significant difference 0.2% (from 0.3e0.5% per NAR).5
Eisele noted that in order to show a reduction in the RLN
paralysis rate from 2% to 1% per NAR, a study group of
approximately 1000 patients would be needed.40 Further
randomized controlled trials are needed to confirm these
results. Unfortunately, a prospective, multicenter,
randomized, control study is difficult to perform because
many patients and surgeons expect nerve monitoring to
supply additional benefits, thus limiting randomization to
a non-IONM control group.12 Most articles neglected to
describe or even mention the circumstances of any unin-
tentional RLN injuries, which made this comparison diffi-
cult to assess. A study based on a systematic appraisal of
the literature using evidence-based criteria reached the
conclusion that apart from navigating the surgeon through
challenging anatomies, IONM may be useful as a routine
adjunct to the gold standard of visual nerve identication.30
However, a meta-analysis performed by Thomas, which
included one randomized clinical trial, seven comparative
trials, and 34 case series, demonstrated no statistically
significant differences in the rates of RLN palsy after using
IONM versus recurrent laryngeal nerve identification alone
during thyroidectomy. Obviously, this conclusion is
contradictory to our results. In our meta-analysis, two
randomized clinical trials and 12 comparative trials were
included without a case series. As Thomas discussed in his
study,28 case series involve biases, including inherent
selection bias, publication bias, allocation bias,
measurement bias, and intervention bias. These biases
may contribute to these diverse outcomes. In the meta-
analysis performed by Thomas, subgroup analyses were
also performed, which showed that none of these
comparisons demonstrated statistically significant differ-
ences. In fact, the individual patient dates (IPDs) of the
studies included in the Thomas study and ours were
imperfect. It is possible that differences between
subgroups might disappear or become significant with
detailed IPDs.
The large number of studies suggesting the utility of
IONM11e23 and its current clinical use indicate the urgent
need for a well-designed study that assesses its accuracy
and clinical value. The current lack of sufficient evidence
is due to the absence of high-quality evidence-based
studies that have investigated these applications. The
studies that are currently available on this issue
include biases and lack standardized methodology.Randomization is a critical feature of study design that
should be included in future studies. To determine the
utility of IONM in the prevention of RLN palsy, clinical
investigators need to randomly bring patients into
experimental and control groups. Additional evidence-
based studies are recommended to verify the value of
IONM, the optimal electrode type for specific situations,
and the relationship with prevention outcomes. Post-
operative laryngoscopic examination should be per-
formed within 24 hours after surgery and then
periodically until paralysis resolves. We recommended
a definition of persistent vocal fold palsy as palsy lasting
no less than 12 months. Complete demographics (e.g.,
age, gender, pathology, surgery) and subgroup stratifi-
cation analyses should also be included.
This study has several limitations that merit further
discussion. Although we have made attempts to be as
inclusive and as transparent as possible when generating
our search strategy, there may be articles that were inad-
vertently filtered out by our search parameters. In addition,
excluding non-English articles does introduce potential bias
to our review. Additionally, we limited our review to pub-
lished articles and did not perform a deliberate search for
unpublished data. It is well known that heterogeneity is an
inherent limitation to meta-analysis. This was addressed in
our study using standard meta-analytic techniques,
including the Cochrane Q and Tau2 statistics, random
effects analysis, sensitivity analysis, and standardized
article selection criteria. Subgroup analysis was not per-
formed because of the insufficient data supplied in the
included studies.
Based on this meta-analysis, we were able to identify
statistically significant differences in the incidences of
total and transient RLN palsy after using IONM versus RLN
identification alone during routine thyroidectomy, though
a hypersensitivity was revealed in the pooled analysis of
the transient RLN palsy rate. However, no statistically
significant difference was identified in the incidence of
persistent RLN palsy between the IONM group and without
IONM group. Hopefully, this review will lead to more high-
level studies, and, in the future, more can be stated
regarding the incidence of recurrent laryngeal nerve palsy
with and without IONM during thyroidectomy.Disclosures
The authors have no competing interests or sponsorships to
declare.
Appendix 1
Search strategy
Data bases Search strategy Results
PUBMED (1950 e April, 2011) 1. thyroidectomy [mh]
2. (Thyroid Gland [mh] OR thyroid [tw]) AND Surgical Procedures,
Operative [mh]
3. OR/1-2
5. vocal cord paralysis [ mh]
6. (Vocal fold* [tw] OR Vocal cord* [tw]) AND (immobility [tw] OR
palsy [tw])
7. (Inferior Laryngeal Nerve* [tw] OR Recurrent laryngeal nerve* [tw]) AND
palsy [tw]
8. OR/5-7
9. monitoring, intraoperative [mh]
10. (Intraoperative [tw] OR Intra-operative [tw]) AND (neuromonitoring
[tw] OR monitoring [tw] OR neurostimulation [tw] OR nerve
Monitoring [tw])
11. Electrophysiologic monitoring [tw]
12. laryngeal electromyography [tw]
13. or/9-12
14. 3 and 8 and 13
119
Cochrane Central Register of Controlled
Trials (CENTRAL, The Cochrane
Library, Issue 2 of 4, Apr 2011)
#1. MeSH descriptor Thyroid Gland explode all trees
#2. thyroid*
#3. MeSH descriptor Surgical Procedures, Operative explode all trees
#4. (#1 OR #2) AND #3
#5. MeSH descriptor Thyroidectomy explode all trees
#6. thyroidectom*
#7. (#5 OR #6)
#8. MeSH descriptor Vocal Cord Paralysis explode all trees
#9. (Vocal fold*) or (Vocal cord*)
#10. (immobilit*) or (pals*)
#11. #8 OR (#9 AND #10)
#12. MeSH descriptor Recurrent Laryngeal Nerve explode all trees
#13. (Inferior Laryngeal Nerve*)
#14. (Recurrent laryngeal nerve*)
#15. #12 OR #13 OR #14
#16. MeSH descriptor Monitoring, Intraoperative explode all trees
#17. (neuromonitoring) or neurostimulation or nerve Monitoring or
(monitoring)
#18. (Intraoperative) or (Intra-operative)
#19. #16 OR (#17AND #18)
#20. Electrophysiologic monitoring
#21. (laryngeal electromyography)
#22. #19 OR #20 OR #21
#23. (#4 OR #7) AND #11 AND #15 AND #22
4
EMBASE (1974 e April, 2011) #1. ‘thyroid gland’/exp
#2. thyroid*
#3. ‘surgery’/exp
#4. #1 OR #2
#5. #3 AND #4
#6. thyroidectom*
#7. ‘thyroidectomy’/exp
#8. #6 OR #7
#9. #5 OR #8
#10. vocal AND fold*
#11. vocal AND cord*
#12. #10 OR #11
#13. immobilit*
83
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Appendix 1 (continued )
Data bases Search strategy Results
#14. pals*
#15. #13 OR #14
#16. #12 AND #15
#17. ‘vocal cord paralysis’/exp
#18. #16 OR #17
#19. inferior AND laryngeal AND nerve*
#20. recurrent AND laryngeal AND nerve*
#21. ‘recurrent laryngeal nerve’/exp
#22. #19 OR #20 OR #21
#23. ‘neuromonitoring’/de OR neuromonitoring
#24. ‘neurostimulation’/de OR neurostimulation
#25. ‘nerve’/de OR nerve AND (‘monitoring’/de OR monitoring)
#26. ‘monitoring’/de OR monitoring
#27. #23 OR #24 OR #25 OR #26
#28. electrophysiologic AND(‘monitoring’/de OR monitoring)
#29. laryngeal AND(‘electromyography’/de OR electromyography)
#30. #27 OR #28 OR #29
#31. intraoperative
#32. ‘intra operative’
#33. #31 OR #32
#34. #30 AND #33
#35. ‘patient monitoring’/exp
#36. #34 OR #35
#37. #9 AND #18 AND #22 AND #36
Others 0
Total 206
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